RSS

FITX Creative Edge Nutrition Inc.

Last Post: 04/16/26
Followers: 292
Posts Today: 0
Views Today: 2477

FITX Stock Quote & Tools

$0.0000 ▲ +0.0000 (+0.00%) As of Nov 6, 9:30 AM EST
Last0.0000
$ Chg0.0000
Open0.0000
High0.0000
Beta100.6055
Year High0.000
Market Cap4.6K
P/B Ratio—
EPS—
Avg Vol (30d)301.4K
Volume472.4K
% Chg+0.00%
Prev Close0.0000
Low0.0000
VWAP0.00000
Year Low0.000
Total Shares—
Shares Out4.63B
Float4.63B
ExchangeCV EM
Healthcare Pharmaceuticals

FITX Stock Message Board Discussion

  1. qwertyfoobar

Top 10 Most Recent News Articles

Segway Powersports Ventures into Baja 1000: Ambitions Run High

Updated Category News Views 124

They're gunning for glory in the sands of Baja, folks—Segway Powersports is about to rev up the excitement with its Baja 1000 debut. Never heard before in this legendary race's chronicles, Segway aims to shake up the game with their two brawny Super Villain UTVs. These aren't your run-of-the-pavement ride-ons; they're built for the rough stuff—and if there's a stage...

Continue Reading
Strathcona and Greenfire Set Sights on Major Merger

Updated Category News Views 156

Strathcona's Bold Move for Greenfire: A Game Changer? Just this week, Strathcona Resources Ltd. decided to make a big splash in the oil sands space by proposing to acquire Greenfire Resources Ltd. This isn’t your run-of-the-mill grab—it's a strategic tango expected to shift billions and reshape what we know about Canada’s oil sands territory. Unpicking the Deal...

Continue Reading
Allergan Aesthetics Study Shows Rising Patient Satisfaction

Updated Category News Views 474

Enhanced Patient Satisfaction with Aesthetic Treatments Dive into the latest studies from Allergan Aesthetics—AbbVie's heavyweight in the beauty battleground. If you've got an ounce of optimism left in this market, their recent findings might just lift your spirits. Phase 4 studies, namely HARMONY IN DIVERSITY and HALO, are showing highly positive results among patients...

Continue Reading
ASTS Faces Class Action; Investors Beware of Pitfalls

Updated Category News Views 345

Securities Fraud Allegations Hit AST SpaceMobile Days like this remind me why we keep our eyes peeled in the stock game—AST SpaceMobile (NASDAQ: ASTS) is tangled in a web of legal drama, and it's something you can't brush off with a shrug. Class action lawsuits for securities fraud? That's like finding out the foundation's shaky beneath a skyscraper. If you've got skin...

Continue Reading
Cleaner Air in Bedroom May Stabilize Blood Sugar Levels

Updated Category News Views 450

Imagine a world where simply sleeping in cleaner air could affect your blood sugar. Seems far-fetched, I know. But that's where we're at with this new study out of NYU Langone Health. They're talking about using plain ol' portable air filters to help steady blood sugar levels for folks dealing with prediabetes. Turns out a cleaner bedroom might just hold the key to taming...

Continue Reading
Onodrim Raises $300M to Propel EU Defence Future

Updated Category News Views 15

Onodrim Industries' Bold Bid to Reshape European Security Right out of the gate, Onodrim Industries is thundering onto the scene with a hefty $300 million Series A round to flex its muscles across Europe's defence and industrial sectors. This ain't your run-of-the-mill startup story. This is about flexing hard-earned capital to snap up established players and inject a...

Continue Reading
Gildan's Crisis: Investors Face Losses Amid Lawsuit

Updated Category News Views 341

Gildan Investors, Brace Yourself Poor old Gildan Activewear finds itself in hot water again, with a class action lawsuit cropping up like an unexpected storm on farmers' day. Any traders remotely involved with NYSE:GIL should pay damn close attention, because with a December 14, 2026 deadline looming, it's crunch time. The Root of the Lawsuit The plot thickens here,...

Continue Reading
Novo's Semaglutide Shows Promise in MASH Study

Updated Category News Views 490

Semaglutide, a name on the lips of many investors looking for breakthroughs, is making waves again. This time, the stir comes from recent findings in the MASH field, and it's got folks in white coats quite excited. Revolutionary Results from Novo Novo Nordisk has announced promising results from their phase 3 ESSENCE trial that looks into semaglutide's effects on a...

Continue Reading
Antengene’s AnTenGager-D2 Advances in Cancer Treatment

Updated Category News Views 99

Antengene's AnTenGager-D2 Offers Fresh Hope Alright, let's dig into the latest buzz from the 2026 Society for Immunotherapy of Cancer conference about Antengene's AnTenGager-D2 platform. If you're not into biotech lingo, buckle up, because this is a ride into the future of cancer treatments—where science fiction might soon become science fact. A Novel Approach to Tumor...

Continue Reading
D-Wave's Legal Trouble: Securities Fraud Suit Looms

Updated Category News Views 481

A Looming Legal Storm for D-Wave Investors Call it another day, another legal tangle in the investing world. This time, it's D-Wave Quantum Inc. (NASDAQ: QBTS) on the receiving end of a securities fraud class action lawsuit. Yeah, those fancy quantum computers they're pushing didn't predict this one coming. The legal arena is getting ready for a bout, and if you've got...

Continue Reading

Top 5 Most Recently Viewed Articles

Understanding AMETEK's Short Interest and Investor Sentiment

Updated Category News Views 163

Understanding AMETEK's Short Interest AMETEK Inc (NYSE: AME) has recently seen a notable increase in short interest, with a 13.54% rise reported in its short percent of float. Currently, there are approximately 2.23 million shares sold short, equating to about 1.09% of all available regular shares. Given the current trading dynamics, traders would need about 1.43 days on...

Continue Reading
Hub Group Announces Quarterly Dividend for Investors

Updated Category News Views 126

Overview of Hub Group's Quarterly Dividend Announcement Hub Group, Inc. (NASDAQ: HUBG) has recently made headlines by declaring a quarterly cash dividend of $0.125 per share. This announcement comes directly from the company’s Board of Directors, showcasing their commitment to returning value to shareholders. The dividend reflects Hub Group's growth-focused capital...

Continue Reading
EfTEN United Property Fund's NAV Rises Slightly Amid Trends

Updated Category News Views 169

EfTEN United Property Fund's NAV Update The net asset value (NAV) of the EfTEN United Property Fund units reached 11.34 euros by the end of September, marking a modest month-on-month increase of 0.33%. This relatively small gain in NAV was influenced by the investment in EfTEN Real Estate Fund AS. The shares of this fund closed at 0.8% lower compared to the previous month...

Continue Reading
SDi Analyzes Key Trends in Lab Instrument Market for 2025

Updated Category News Views 162

Understanding the Laboratory Instruments Market Trends Strategic Directions International (SDi) has unveiled its pivotal report which dives deep into the global laboratory instrumentation market, showcasing insights about the competitive landscape. This analysis focuses on the performance of leading instrument manufacturers, providing a comprehensive understanding of...

Continue Reading
Davis Commodities Secures USD 30 Million for Growth Initiatives

Updated Category News Views 272

Davis Commodities Inc. Takes a Bold Step Forward Davis Commodities Limited (NASDAQ: DTCK) is initiating a transformative phase through the issuance of new shares valued at USD 30 million. This strategic decision marks a significant milestone for the company, aligning with its vision to enhance growth and expand operational capabilities. Advantages of Issuing New Shares...

Continue Reading